This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Medizinische Hochschule Hannover. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: David Schwarzer: Innovator in Anti-Tumor Medicament Development
Introduction
David Schwarzer is a notable inventor based in Hanover, DE. He has made significant contributions to the field of medicine, particularly in the development of innovative treatments for tumors. His work focuses on utilizing manipulated adenoviruses as a therapeutic approach to combat cancer.
Latest Patents
David Schwarzer holds a patent for an anti-tumor medicament based on adenovirus. This invention provides a viral particle derived from a manipulated adenovirus, specifically designed for use as a medicament in tumor treatment. The unique aspect of this viral particle is its preference for tumor cells, which allows for targeted infection and treatment. The adenovirus utilized in this invention is primarily type C, with a focus on serotype 2 (Ad2) and serotype 5 (Ad5). The native fiber protein has been deleted and replaced with a fusion protein that enhances specificity for cell surface-bound polysialic acid.
Career Highlights
David Schwarzer is affiliated with the Medizinische Hochschule Hannover, where he conducts his research and development work. His innovative approach to cancer treatment has positioned him as a key figure in the medical research community.
Collaborations
David collaborates with esteemed colleagues such as Rita Gerardy-Schahn and Florian Kuehnel. Their combined expertise contributes to the advancement of research in the field of oncology.
Conclusion
David Schwarzer's work in developing an anti-tumor medicament showcases his commitment to advancing medical science. His innovative use of manipulated adenoviruses represents a promising avenue for cancer treatment.